Comments
Commented by Stefan Feulner on September 28th, 2021 | 12:04 CEST
Nordex, GSP Resource, NIO - These are the election winners
Germany has voted, and the decision was very close. According to the leading candidates Scholz and Laschet, the government should be in place by Christmas at the latest. Whether it is a traffic light or Jamaica, the Greens will almost certainly be part of the coalition. As a result, this means that the energy transition and climate protection topic will be more in the focus of politics than ever before. The expansion of infrastructure topics such as energy, construction and transport promises growing sources of income and full order books for the companies concerned.
Read
Commented by Carsten Mainitz on September 28th, 2021 | 11:19 CEST
Cardiol Therapeutics, BioNTech, Valneva - Volatility offers good opportunities!
The share prices of the Corona vaccine manufacturers are not growing sky-high after all. Most recently, developments at France's Valneva caused uncertainty. The French Company wanted to bring a Corona vaccine to market by the end of 2021 and had already received an order from the British government for 100 million units. This contract has now been canceled. Where does the industry go from here?
Read
Commented by Nico Popp on September 28th, 2021 | 10:37 CEST
Intel, BrainChip, AMD: A chip like the human brain
Chips are in short supply. When assembly lines in Wolfsburg, Munich or Sindelfingen come to a standstill because of a shortage of inexpensive semiconductors, it is frustrating for the German automotive industry. But powerful chips and processors with entirely new architecture are also urgently needed for future technology. Machine learning and artificial intelligence are also placing new demands on chipmakers. We profile three titles.
Read
Commented by Armin Schulz on September 27th, 2021 | 13:24 CEST
Valneva, Defence Therapeutics, CureVac - Second-tier vaccine makers offer high potential
The battle against the Coronavirus is still ongoing, although more and more people have been vaccinated with vector or mRNA vaccines. In Europe, an average of 60% of all people have received the vaccination. Herd immunity has not yet been achieved, in part because of vaccine skeptics who do not yet trust novel vaccines. New vaccines based on dead viruses promise to remedy the situation. This method has already been tried and tested in influenza vaccinations, for example. According to a study in Switzerland, about 70% of the unvaccinated would still be vaccinated if the method had already been tested. Herd immunity could thus be achieved, and everyday life could return to normal. So, which vaccine manufacturer that does not currently have an approved product could shake up the market?
Read
Commented by André Will-Laudien on September 27th, 2021 | 12:52 CEST
Central African Gold, TUI, Lufthansa - Attention, these were the lows!
The upward movement at the stock exchanges is very advanced because, in the last years, the higher valuation of the shares (and real estate) was funded by cheap money from the central banks. Now, however, inflation shows up in the statistics, for Europe officially a plus of 3,8%. This inflation rate, by its measuring method, corresponds little to reality. It is generally known, the actual price markup in the relevant goods might already lie beyond the 5% mark. One thinks here only of the exploding gasoline prices, the bread roll at the baker or the restaurant attendance after the reopening. Precious metals could be a tried and tested means of achieving real purchasing power protection. Let us do the math.
Read
Commented by Carsten Mainitz on September 27th, 2021 | 12:20 CEST
Diamcor Mining, TUI, Xiaomi - Consumer stocks are among the winners!
To consume or to save? Everyone is faced with this fundamental decision. The individual rate depends on the level of income and the prospects regarding the labor market and economic growth. In the course of the Corona pandemic, private consumption declined significantly. With economic recovery and the removal of lock-downs, personal consumption is picking up again considerably. The companies mentioned above are benefiting from this.
Read
Commented by Stefan Feulner on September 27th, 2021 | 11:23 CEST
JinkoSolar, dynaCERT, Alstom, Nel ASA - Hydrogen as the key
For the first time right before a federal election, Fridays for Future demonstrated nationwide for more climate protection. According to Greta Thunberg, who made her appearance in Berlin, Germany is the fourth-largest carbon dioxide emitter in history, and that with a population of only 80 million people. Politicians must act and accelerate the switch from gasoline and diesel to environmentally friendly drives. In addition to electromobility, there is no way around hydrogen and fuel cell technology in the future, especially for heavy vehicles.
Read
Commented by Nico Popp on September 27th, 2021 | 10:46 CEST
BioNTech, Meta Materials, Bayer: Rich with innovations
A new car manufacturer or a new networked fitness device can trigger hype on the stock market. But the opportunities are even greater when companies bring genuine innovations to market. These include new active ingredients, pharmacological processes or pioneering achievements by engineers. We present innovators of yesterday, today and tomorrow and shed light on their growth prospects.
Read
Commented by Fabian Lorenz on September 24th, 2021 | 14:10 CEST
BioNTech, Valneva, Defence Therapeutics: New highs for vaccine stocks?
Investors in COVID-19 vaccine manufacturers have had little reason to rejoice in recent weeks. Top dogs Moderna and BioNTech have come back noticeably from their highs. Valneva's stock plummeted on Monday. Only newcomer Defence Therapeutics has held its ground at a high level. But for all of them, the calm could soon be over, and a new high could begin. Because people in other parts of the world are still not vaccinated. In addition, winter is just around the corner in Western countries, which means that Corona rates are rising. In addition, a new study shows the risk of long-COVID - such as memory and concentration deficits - even in children. With this mix, vaccine stocks face an exciting fall.
Read
Commented by André Will-Laudien on September 24th, 2021 | 13:34 CEST
Tencent, Memiontec, Gazprom - Buy when the cannons are firing!
The last few trading days have been dominated by the scandal surrounding China Evergrande. To take pressure off the markets, the management and China's central bank have reacted accordingly and presented measures. The highly indebted real estate company has probably reached an agreement with domestic creditors regarding the outstanding interest payments. No mention was made of offshore liabilities. The People's Bank of China has reportedly injected 90 to 110 billion yuan, the equivalent of just under 14 billion euros, into the banking system in an attempt to calm investors' nerves. Nightingale, "we" hear you galumph!
Read